October 10,2020 Update
Blood transfusion medicine is becoming increasingly necessary in Japan where the population is aging, but the reduction in the number of blood donors has been unstoppable and it has become increasingly difficult to secure sufficient blood products. We believe that transfusion monitoring and clinical support by the Department of Transfusion Medicine and Cell Therapy staff is one of the indispensable activities in order to practice the most important "patient-oriented transfusion therapy (patient blood management)" in transfusion medicine, and in order to effectively utilize the limited blood resources. In addition, the support of the medical departments with the group of blood transfusion specialists is an important responsibility while the importance of transfusion therapy for hemostasis purpose is emphasized.
As a university hospital rooted in the region, our clinic has a large number of patients with a high level of severity and urgency, and the amount of blood products used for transfusions is greater than 500 million yen annually. We don't need to talk about the need and usefulness of transfusion medicine, but the safety is more important and we recognize that the staff involved in transfusion have a serious responsibility. All of the staff of the Department of Transfusion Medicine and Cell Therapy believe that working on every single task quickly and steadily on a daily basis will lead to the happiness of the patient.
The Department of Transfusion Medicine and Cell Therapy cooperates with the medical departments and conducts daily business with the aim of promoting the safe and proper use of blood products. We consult on the transfusion adaptation and dosages as well as administration of plasma fraction products for hemostasis, in addition to the selection and dispensing service of blood products in transfusions for outpatient, the ward, and the operating room, etc. A computer authentication system using bar codes has been adopted for managing, dispensing and administering blood products to minimize the risk of transfusion accidents caused by human error. It also plays an important role in the collection and storage of hematopoietic stem cells for advanced therapies such as peripheral blood stem cell transplantation. In addition, we undertake the collection and storage of the own-blood of patients for elective surgery, mainly in the Department of Obstetrics, Orthopaedic Surgery, and Urology.
On the other hand, the main inspection services are blood type testing, irregular antibody testing, cross-conformity testing, infectious disease (hepatitis virus antibody) testing, HLA testing, and CD34-positive cell measurement. Patients for whom irregular antibodies against red blood cells have been detected are given an "irregular antibody card," and we strive to share the antibody information with other medical institutions. In addition, we have created and given a "post-transfusion infectious disease test card" to patients who receive blood transfusions in order to promote post-transfusion infectious disease testing and are working to improve the implementation rate.
In addition, we are working 24 hours a day for orders and dispensing services for transfusion tests and blood products / plasma fraction products, with the cooperation of the Department of Clinical Laboratory.
|Name||Job Title||Position||Specialized Field||Credentials|
|Professor||Chief of Clinical Services
Chief of Education
Blood Coagulation and Fibrinolysis
|The Japan Society of Transfusion Medicine and Cell Therapy Authorized Doctor
Board Certified Member of the Japanese Society of Hematology・Supervised Doctor
Managing Doctor of the Japanese Society of Laboratory Medicine
Board Certified Member/Ferrow of the Japanese Society of Internal Medicine
|Department of Transfusion Medicine and Cell Therapy|
Our hospital Department of Transfusion Medicine and Cell Therapy has a yearly blood transfusion that is always competing for #1 or #2 in the prefecture, and there is a tremendous amount of work for transfusion testing and dispensing service of blood products / plasma fraction products. Considering the recent situation in which the proper treatment of transfusion therapy is strongly emphasized, not only red blood cell preparations, but also fresh frozen plasma and platelet preparations are also checked for blood transfusion appropriateness and we consult with the medical departments as needed. Based on the concept of "a proper blood transfusion" = "the effective minimum transfusion," we believe that the transfusion order check by the Department of Transfusion Medicine and Cell Therapy staff is an essential process in order to promote proper blood transfusions. Also, the thawing of fresh frozen plasma can be performed in the Department of Transfusion Medicine and Cell Therapy, which not only to reduces the workload of the staff of the medical departments but contributes to the reduction of the dose itself. Plasma fraction products are also collectively managed by the Department of Transfusion Medicine and Cell Therapy, and the proper use is promoted for albumin preparations as a starting place. These efforts have achieved a significant reduction in blood product waste (less than one-quarter of what it was three years ago), not to mention the continuous acquisition of transfusion management fees I, and they contribute to the effective use of valuable blood resources.
In addition, we have been involved in recent years in transfusion therapy for bleeding patients who need a large amount of blood transfusions and are leading to transfusion therapy for hemostasis purposes such as the timing of dosing of platelet preparations and coagulation factor formulations. The active administration of concentrated fibrinogen formulations is promoted and it contributes significantly to the survival and prognosis improvement of the patients, in particular, for advanced low fibrinogen blood disease, which is a major cause of mass bleeding in patients with multiple traumas and maternity bleeding.
In this way, our Department of Transfusion Medicine and Cell Therapy is working on the ultimate business goal of providing safe transfusion medicine that is beneficial to patients and not wasteful.